The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,843 units of the pharmaceutical product GAMUNEX-C 20 gram/200 ml vial. The contract has a ceiling value of $7,147.50 and a period of performance through April 22, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $14,427.24 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4564767201 GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with a performance period ending on June 24, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $14,982.10 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of GAMUNEX-C 10 gram/100 ml vials with a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $57,708.96 to AmerisourceBergen Drug Corp for the supply of 40-gram/400-mL vials of the pharmaceutical product GAMUNEX-C. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA and AmerisourceBergen for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
The Defense Logistics Agency (DLA) awarded a $14,295.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The order is for 200 ml vials of GAMUNEX-C, a pharmaceutical product, with a completion date of March 7, 2024. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This is a firm fixed-price delivery order worth $7,213.68, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product, with a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its extensive federal contracting activities to supply a wide range of essential medical...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract is a firm fixed price award with a potential value of $48,090.80 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The $9,530 contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC) with a...